MCB After the Print: Call Buyers Rewarded, Insiders Still Selling

Short interest has crept up modestly, but the story there is not dramatic. SI now stands at 5.9% of the free float, up about 3.2% on the week and 5.1% over the past month, drifting slowly higher from the low-600k share range it has occupied most of June. The short score of 42.6 ranks in the bottom fifth of the universe on a percentile basis, meaning bears have not built an aggressive position. The slow accumulation is worth monitoring, but it looks more like passive drift than a conviction short thesis forming.

The Street picture is mixed and skewed toward optimism, though most of the formal analyst activity predates today's print. Keefe, Bruyette & Woods maintained an Outperform in April with a $109 target, while UBS initiated at Neutral with a $97 target — the two most recent moves pulling in opposite directions. The consensus mean target of $112.67 sits about 14% above the current price, which implies the Street as a whole still sees room to run. On valuation, MCB trades at roughly 8.9x trailing earnings and 1.1x book — modest multiples for a regional bank approaching its 52-week high. The EPS surprise factor score ranks in the 92nd percentile, suggesting the company has consistently beaten estimates; the 90-day EPS momentum score matches that, also at 92. What drags on the picture is the 30-day EPS momentum score, which sits at just 29, a sign that near-term estimate revisions have softened.

The insider activity remains the clearest counterweight to the bullish setup. Net insider selling totalled roughly $1.9 million over the past 90 days. Director Robert Patent sold 15,000 shares across two tranches in early June at prices between $90 and $96. An EVP sold a further 2,250 shares in late June and early July near $100. The CFO's March purchase of 1,000 shares at $79.95 is the only buying in the window, and at $80k it is dwarfed by the selling in aggregate. Institutional flows tell a different story — Wellington Management added over 610,000 shares in Q1, Citadel built a new stake of nearly 295,000 shares, and both UBS Asset Management and Millennium Management each added more than 260,000 shares. The divide between institutional accumulation and insider distribution is the central tension in the ownership picture.

With the Q2 print now behind it, the next question for MCB is whether post-earnings analyst revisions shift the consensus target materially — and whether insider selling continues as the stock holds near $100 for the first time.